Ventricular assist devices are the standard of care for bridging end-stage heart failure patients to transplantation, though data on bridging to recovery remains sparse.
Answers are grounded in this paper and cite their sources.
Reinforces VADs for transplant bridging in end-stage HF; leaves open their role in recovery and need for prospective trials.
Ventricular assist devices have emerged as the standard of care in treating end-stage heart failure. Their success in bridging patients to transplantation is well documented. The data supporting their ability to bridge patients to recovery is sparser. However, as technology continues to advance, these devices will offer a high quality of life both in and out of the hospital setting, making them options for a broader spectrum of heart failure patients.
No takes yet. Share an insight, caveat, or question.
Kherani et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: